11th Neurological Disorders Summit | Neurological Disorders Conference

11^th Neurological Disorders Summit (NDS-2026)

July 06-08, 2026 | Boston, MA
Venue: Four Points by Sheraton Wakefield Boston Hotel &
Conference Center

About NDS-2026

We welcome you to the 11^th Neurological Disorders Summit (NDS-2026) on July 06-08, 2026, in Boston, MA.
The NDS-2026 summit offers a unique opportunity for neuroscientists and physicians to share their research and experiences with leading experts in their fields. The program features keynote speeches from internationally renowned scientists who have shaped modern neuroscience concepts. Additionally, there will be sessions for oral and poster presentations, providing an overview of cutting-edge technologies used to address challenging therapeutic and theoretical issues in neuroscience. NDS-2026 stands out for fostering dialogue between basic and clinical scientists, facilitating these exchanges during both scientific sessions and networking events. The summit aims to be particularly educational and inspiring for young scientists, offering them the chance to interact with leading experts. Germany, the host city, is home to top medical research centers and laboratories and boasts many award-winning ethnic and continental food choices. We are proud to welcome you to this exciting summit and hope you will find the academic and social interactions in Germany rewarding.

Scientific Sessions

Neurological disorders: Symptomatology, pathophysiology and etiology
Diagnostics of neurological disorders: Neuroimaging, biomarkers and laboratory studies
Alzheimer's disease, dementia and mild cognitive impairment
Parkinson's disease and other movement disorders
Neuromuscular disorders and peripheral neuropathies
Neurodegenerative diseases
Neuropathological disorders
CNS Neoplasia
Neurotransmitters, neuropeptides and drug targets‏

Neurobehavioral disorders
Prevention, treatment and therapeutic options
Autism and neurodevelopmental disorders
Epilepsy and seizure
Advances in stroke management
Stroke: Prevention, treatment and recovery
Multiple sclerosis and CNS demyelinating disorders
Migraine and headaches
Neuroengineering & rehabilitation
Case studies and ethical issues

Poster presenter Winners

Sofia Vrettou

University of Cologne, Germany
Title: Dysregulated S-glutathionylation and Redox Enzymes in Multiple Murine Organs of Spinal Muscular Atrophy

Hind A. Beydoun

University of Texas Health Science Center at Houston, USA
Title: Mediating and Moderating Effects of Plasma Proteomic Biomarkers on the Association Between Poor Oral Health Problems and Incident Dementia: The UK Biobank Study

Amy Glynn

SMATHERIA, Germany
Title: Peripheral Organs Defects in Spinal Muscular Atrophy: Actin Dysregulation

Ethel Virginia Sticinski

University of Delaware, USA
Title: Caregiver Strain and Quality of Life: Assessing the Moderating Role of Age Among Caregivers of Offspring with Intellectual and Developmental Disabilities

Johanna Mitterreiter

Siemens Healthineers, Germany
Title: Screening for Early Biofluid Markers of Alzheimer’s Disease in an At-risk Population: Design of the PREDICTOM Study

Eulalia Gomez Armengol

Ghent University, Belgium
Title: Ectoine Treatment Stimulates Protein Markers of Autophagy Efficiency in the Duchenne Muscular Dystrophy Mouse Model mdx

2025 Organizing Committee

Laxman D. Gangwani

University of Missouri
USA

Kenneth Blum

Western University College of Medicine, USA
Co-Chair

Jin Jun Luo

Temple University,
USA
Member

Rajendra D. Badgaiyan

Texas Tech University Health Sciences Center, USA
Member

View More

Pre Early Bird Registration

Academic

$ 699

Welcome coffee
Access to All Talks + Posters
Conference material
Lunch, tea / coffee breaks
WiFi in meeting rooms

Industry

$ 799

Welcome coffee
Access to All Talks + Posters
Conference material
Lunch, tea / coffee breaks
WiFi in meeting rooms

Student

$ 399

Welcome coffee
Access to All Talks + Posters
Conference material
Lunch, tea / coffee breaks
WiFi in meeting rooms

Virtual

$ 329

Access to All Talks + Posters
Conference material

Report on the 10^th Neurological Disorders Summit (NDS-2025)

The 10^th Neurological Disorders Summit (NDS-2025) organized by United Scientific Group was held from April 28, 2025 to April 30, 2025 in Hybrid mode (In-person & Virtual). 123 attendees from more than 25 countries presented at NDS-2025 over 3 days with 2 Plenary and 3 keynote lectures, 70 oral and 25 poster and 1 Sponsor presentations. Of the Plenary speakers, opening talk given by Dr. Giulio Maria Pasinetti, Icahn School of Medicine at Mount Sinai, USA on “Role of the Immune T Regulatory Cells in Mood Disorders and Alzheimer’s Disease Phenotype as a Therapeutic Target in Altered Gut-brain Axis Cross-talking”. Dr. Hossein Ansari, University of California, USA & Ali Totonchi, Metro Health Medical Center, USA presented “Role disease Deactivation of Peripheral Nerves for the Management of Migraine Headache”. Dr. Jin Jun Luo, from Temple University, USA Lectured “The Link Between Vitamin D Deficiency and Peripheral Neuropathy: A Risk Factor?”. Dr. Rajendra D. Badgaiyan, from Texas Tech University Health Sciences Center, USA on “A Novel Approach to Diagnose and Treat Neurological Disorders”. Dr. Niketa A. Patel from JAH VA Hospital and University of South Florida, USA on “Intranasal Delivery of Human Adipose Stem Cells Derived Exosomes for Treatment of Traumatic Brain Injury “ and last keynote talk given by Dr. Kenneth Blum (Co-Chairman of NDS-2025), Western University College of Medicine, USA on “Gwas & Pharmacogenomic Evidence for Genetic and Epigenetic Correlates of Reward Deficiency Syndrome(Rds) : A New Era in Evidence Based Data”.